Literature DB >> 19949005

Hunting and trapping the vascular endothelial growth factor.

Afshin Dowlati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949005     DOI: 10.1200/JCO.2009.25.4359

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2.

Authors:  Jaya Prabhakaran; Victoria Arango; Vattoly J Majo; Norman R Simpson; Suham A Kassir; Mark D Underwood; Hanish Polavarapu; Jeffrey N Bruce; Peter Canoll; J John Mann; J S Dileep Kumar
Journal:  Bioorg Med Chem Lett       Date:  2012-06-07       Impact factor: 2.823

2.  A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors.

Authors:  Justine Yang Bruce; Patricia M LoRusso; Priscila H Goncalves; Elisabeth I Heath; Elizabeth Sadowski; David R Shalinsky; Yanwei Zhang; Anne M Traynor; Aurora Breazna; Alejandro D Ricart; Michael Tortorici; Glenn Liu
Journal:  Cancer Chemother Pharmacol       Date:  2016-01-20       Impact factor: 3.333

3.  Novel antibody-based proteins for cancer immunotherapy.

Authors:  Jaheli Fuenmayor; Ramon F Montaño
Journal:  Cancers (Basel)       Date:  2011-08-19       Impact factor: 6.639

4.  A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer.

Authors:  H Chen; M R Modiano; J W Neal; J R Brahmer; J R Rigas; R M Jotte; N B Leighl; J W Riess; C J Kuo; L Liu; B Gao; A T Dicioccio; A A Adjei; H A Wakelee
Journal:  Br J Cancer       Date:  2013-11-28       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.